Report of foreign issuer [Rules 13a-16 and 15d-16]

Share Based Compensation (Tables)

v3.25.3
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Shareholders’ Equity [Abstract]  
Schedule of Stock Option Activity A summary of the stock option activity under the Company’s equity plans during the nine months ended September 30, 2025 is as follows:
   

Outstanding

share options

    Weighted-average exercise price ($)     Weighted average remaining contractual life (years)     Aggregate intrinsic value ($ in thousands)  
Options:                        
Outstanding as of December 31, 2024     4,590,375       4.62       5.87       1,364,975  
                                 
Granted     360,000       1.31       6.04       -  
Forfeited     (14,664 )     4.14       -       -  
Expired     (272,040 )     7.28       -       -  
Exercised     (360,601 )     1.22       -       -  
Outstanding as of September 30, 2025     4,303,070       4.47       5.54       988,581  
                                 
Exercisable as of September 30, 2025     3,593,284       4.77       4.93       867,261  
                                 
Options available for future grants     1,993,005                          
Schedule of RSUs Activity

A summary of the Company’s RSUs activity during the nine months ended September 30, 2025 is as follows:

 

    Numbers of RSUs  
RSUs:      
Outstanding as of December 31, 2024     4,913,123  
Granted     2,426,337  
Forfeited     (264,466 )
Vested     (3,841,680 )
Outstanding as of September 30, 2025     3,233,314  
Schedule of Compensation to Employees

The following table set forth the parameters used in the computation of the options compensation to employees:

 

   

Nine months ended

September 30,

 
    2025     2024  
             
Expected term, in years     5.81       6.11  
Expected volatility     51.88 %     51.75 %
Risk-free interest rate     3.64 %     4.23 %
Expected dividend yield     0 %     0 %
Schedule of Share Based Compensation Expense The following table presents share-based compensation expense for employees included in the Company’s consolidated statements of operations:
   

Nine months ended

September 30,

 
    2025     2024  
             
Research and development     5,042       7,731  
Sales and marketing     1,320       1,845  
General and administrative     1,088       1,601  
Cost of revenues     125       222  
                 
Total stock-based compensation expense     7,575       11,399